ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Janssen's lead coronavirus vaccine shows preclinical promise pharmatimes
September 07, 2020Janssen’s lead SARS-CoV-2 investigational vaccine candidate, Ad26.COV2.S, prevented severe clinical disease in Syrian golden hamsters when challenged with SARS-CoV-2, the virus that causes COVID-19 in people. -
Janssen to Discontinue Pimodivir Influenza Development Program americanpharmaceuticalreview
September 04, 2020The Janssen Pharmaceutical Companies of Johnson & Johnson has made a strategic decision to discontinue the development of pimodivir, an investigational antiviral treatment for influenza A infection.
Pharma Sources Insight July 2025
